Accepting New Patients
C Noel Bairey Merz, MD
IM Cardiology
310-423-9680
Fax: 310-423-9681
From You
Call to Schedule
4.7
25 Reviews
4.7
25 Reviews
Languages
- English,
Gender
Female
Experience
42 Years
Locations
Smidt Heart Institute
Smidt Heart Institute
Monday: 8:00AM - 5:00PM
Tuesday: 8:00AM - 5:00PM
Wednesday: 8:00AM - 5:00PM
Thursday: 8:00AM - 5:00PM
Friday: 8:00AM - 5:00PM
When you arrive
- Pavilion is located at 127 S. San Vicente Boulevard between West 3rd Street and Gracie Allen Drive. Valet parking and self-parking are available in the Pavilion Parking lot, located on Sherbourne Drive between West 3rd Street and Gracie Allen Drive. Park in the Gold Zone (Levels B2 and B3) and take the Gold Parking elevators to the Plaza Level. Follow the signs for the Pavilion elevators, and take the elevator up to your destination. For parking rates and hours of operation, please visit cedars-sinai.org/parking
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
1
- IM Cardiology
Programs
Cedars-Sinai clinical programs this provider is part of:
6
Titles
- Director, Barbra Streisand Women's Heart Center
- Director, Linda Joy Pollin Women's Heart Health Program
- Director, Preventive and Rehabilitative Cardiac Center
- Professor, Cardiology
Education & Training
-
Cedars Sinai
Fellowship - Completed 1988
-
Moffitt Hospital, University of California, San Francisco
Residency - Completed 1985
-
Moffitt Hospital, University of California, San Francisco
Internship - Completed 1982
-
Harvard Medical School
Medical School - Completed 1981
Achievements
-
2
Board Certifications
-
8
Awards and Honors
Board Certifications
-
General Internal Medicine
American Board of Internal Medicine
-
IM/Cardiology
American Board of Internal Medicine
Awards and Honors
- First Prize in Cardiology – British Medical Association (BMA) Medical Book Awards 2019, The ESC Textbook of Cardiovascular Medicine, 3rd Edition and ESC CardioMed
- Hopkin Heart, 2nd Annual Visiting Scholar for the Dr. Pamela Ouyang Lectureship in Women’s Cardiovascular Health, Ciccarone Center for the Prevention of Cardiovascular Disease, John Hopkins
- 18th Annual Maseri-Florio International Keynote, 68th Annual Scientific Sessions, New Orleans, Louisiana
- Member, National Heart, Lung, and Blood Institute Council
- Member, Board of Trustees, American College of Cardiology
- Member, National Cholesterol Education Program
- 2020 Cedars-Sinai Medical Center Pioneer in Medicine, Annual Meeting of the Medical Staff, Cedars Sinai Medical Center
- Women's Guild Chair in Women's Health
Publications
- AlBadri A, Bairey Merz C N, Johnson BD, Wei J, Mehta PK, Cook-Wiens G, Reis SE, Kelsey SF, Bittner V, Sopko G, Shaw LJ, Pepine CJ, Ahmed B. Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women. J Am Coll Cardiol. 2019 Feb 19;73(6):684-693. doi: 10.1016/j.jacc.2018.11.040. PMID: 30765035.PMCID: PMC6383781.
- d. Rambarat CA, Elgendy IY, Handberg EM, Bairey Merz CN, Wei J, Minissian MB, Nelson MD, Thomson LEJ, Berman DS, Shaw LJ4, Cook-Wiens G, Pepine CJ. Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study, Int J Cardiol. 2019 Feb 1;276:8-13. doi: 10.1016/j.ijcard.2018.09.081. Epub 2018 Sep 26 PMCID: PMC6324974.
- Weng L, Taylor KD, Chen YI, Sopko G, Kelsey SF, Bairey Merz CN, Pepine CJ, Miller VM, Rotter JI, Gulati M, Goodarzi MO, Cooper-DeHoff RM. Genetic Loci Associated With Nonobstructive Coronary Artery Disease in Caucasian Women. Physiol Genomics. 2015 Nov 3: physiolgenomics. PMCID: PMC4757024.
- b. Sedlak T, Herscovici R, Cook‐Wiens G, Handberg E, Wei J, Shufelt C, Bittner V, Reis SE, Reichek N, Pepine C, Bairey Merz CN. Predicted Versus Observed Major Adverse Cardiac Event Risk in Women with Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation). J Am Heart Assoc. 2020 Apr 7;9:e013234. doi:10.1161/JAHA.119.013234, PMCID: PMC7428651.
- a. Doyle M, Pohost GM, Bairey Merz CN, Shaw LJ, Sopko G, Rogers WJ, Sharaf BL, Pepine CJ, Vidos DA, Rayarao G, Tauxe L, Kelsey SF, McNair D, Biederman RWW. Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). Cardiovasc Diagn Ther. 2013 Dec;3(4):216-27. doi: 10.3978/j.issn.2223-3652.2013.10.07 PMCID: PMC3878119.
- d. Wei J, Bakir M, Darounian N, Li Q, Landes S, Mehta PK, Shufelt CL, Handberg EM, Kelsey SF, Sopko G, Pepine CJ, Petersen JW, Berman DS, Thomson LEJ, Bairey Merz CN. Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease: From the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study. Circulation. 2018 Feb 20;137(8):874-876. doi: 10.1161/CIRCULATIONAHA.117.031999. No abstract available. PMCID: PMC5823279
- c. Nelson MD, Sczdepaniak LS, Wei J, Haftbaradaren A, Bharadway M, Sharif B, Mehta PK, Zhang X, Thomson LE, Berman DS, Li D, Bairey Merz CN, Diastolic dysfunction in women with signs and symptoms of ischemia in the absence of obstructive coronary artery disease: a hypothesis-generating study, Circ Cardiovasc Imaging 2014; (3):510-6. PMCID: PMC4031259.
- b. Wei J, Nelson MD, Szczepaniak EW, Smith L, Mehta PK, Thomson LE, Berman DS, Li D, Bairey Merz CN, Szczepaniak LS. Myocardial Steatosis as a Possible Mechanistic Link between Diastolic Dysfunction and Coronary Microvascular Dysfunction in Women. Am J Physiol Heart Circ Physiol 2015; ajpheart.00612.2015. doi: 10.1152/ajpheart.00612.2015. PMCID: PMC4865076
- a. Thomson, LE, Wei, J., Agarwal, M, Haft-Baradaran, A, Shufelt, C, Mehta, PK., Gill, EB, Johnson, BD, Kenkre, T., Handberg, EM, Li, D, Sharif, B, Berman, DS, Petersen, JW, Pepine, CJ, Bairey Merz, CN. Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute – sponsored study from the Women’s Ischemia Syndrome Evaluation. Circulation Cardiovascular Imaging 2015; 8(4), pii: e002481. doi: 10.1161/CIRCIMAGING.114.002481. PMCID: PMC4375783
- d. Denardo SJ, Wen S, Handberg EM, Bairey Merz CN, Sopko G, Cooper-DeHoff RM, Pepine CJ. Effect of Phosphodiesterase Type 5 Inhibition on Coronary Microvascular Dysfunction in Women: A Women’s Ischemia Syndrome Evaluation (WISE) Ancillary Study. Clin Cardiol 2011; 34: pages 483-487. PMCID: PMC3151010
- c. Bairey Merz CN, Handberg EM, Shufelt CL, Mehta PK, Minissian MB, Wei J, Thomson LE, Berman DS, Shaw LJ, Petersen JW, Brown GH, Anderson RD, Shuster JJ, Cook-Wiens G, Rogatko A, Pepine CJ. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve. Eur Heart J. 2015; pii: ehv647. PMCID: PMC4872284
- b. Bairey Merz CN, Olson MB, McClure C, Yang YC, Symons J, Sopko G, Kelsey SF, Handberg E, Johnson BD, Cooper-DeHoff RM, Sharaf B, Rogers WJ, Pepine CJ. A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: Results from the National Institutes of Health/National Heart, Lung and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE). Am Heart J 2010; 159:987. PMCID: PMC2918903
- a. Pauly DF, Johnson BD, Anderson RD, Handberg EM, Smith KM, Cooper-DeHoff RM, Sopko G, Sharaf BM, Kelsey SF, Bairey Merz CN, Pepine CJ. In women with symptoms of cardiac ischemia, non-obstructive coronary arteries, and microvascular dysfunction, ACE inhibition is associated with improved microvascular function: a double-blind randomized study from the NHLBI Women’s Ischemia Syndrome Evaluation (WISE) Am Heart J 2011;162:678-84. PMCID: PMC3191889
- c. Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, Johnson BD, Sopko G, Bairey Merz CN. Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia: Results from the NHLBI Women’s Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2010; 55(25): 2825-32. PMCID: PMC2898523
- b. von Mering, GO, Arant, CB, Wessel, TR, McGorray, SP, Bairey Merz, CN, Sharaf, BL, Smith, KM, Olson, MB, Johnson, BD, Sopko, G, Handberg, E, Pepine, CJ, Kerensky, RA Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute – Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 2004;109(6), 722-725. PMID: 14970106. PMCID: NA.
- a. Buchthal SD, den Hollander JA, Bairey Merz CN, Rogers WJ, Pepine CJ, Reichek N, Sharaf BL, Reis S, Kelsey SF, Pohost GM. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. New England Journal of Medicine 2000; 342:829-35. PMID: 10727587. PMCID: NA.
Provider Related Blogs
Sex Matters
Finding the Right Care for a Racing Heart
Getting to the Heart of a Microvascular Disease Diagnosis
Healing a Broken Heart
Solving Johanna's Heart Attack Mystery (CMD)
Sarah Vasen: A Pioneer in Obstetrics and Hospital Leadership
American College of Cardiology Honors Women’s Heart Disease Pioneer
KCRW: Heart Disease—Screen Promptly, Especially if You Have Family History
What is MINOCA? A Type of Heart Attack Mostly Affecting Women
The Washington Post: Heart Health, Women and the Limits of Exercise
Symptoms of Common Cardiovascular Condition Can Cause Decline in Physical, Social and Mental Health
Sex Differences and AFib: New Study Flips Conventional Wisdom
Insurances
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Cedars-Sinai location or provider is included in your network.